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INTRODUCTION 
 Diabetic nephropathy and  retinopathy are two frequent complications 
of diabetes mellitus.1They add to the burden of chronic kidney disease and 
blindness respectively.1 These microvascular complications are related to 
the duration of diabetes, poor sugar control and hypertension . 
 
 Diabetic nephropathy is a syndrome comprising of  persistent 
proteinuria, hypertension,a low glomerular filtration rate (GFR).1 
Retinopathy is an important cause of loss of vision in those less than 65 
years.1 
 
 Thirty to 40 % of all type 2 diabetics develop proteinuria .2 Persistant  
proteinuria  is characteristic  of diabetic nephropathy which also requires the 
following criteria to be fulfilled, which are presence of diabetic retinopathy 
and absence of any other kidney disease except for diabetic 
glomerulosclerosis.2 A proteinuric type 2 diabetic can develop other 
glomerular diseases as well .3The presence of such non diabetic lesions in a 
proteinuric type 2 diabetic has been well documented .In one study as high 
as 30 % of the proteinuric diabetics had non diabetic kidney diseases .3 .As a 
spectrum of  non diabetic renal diseases can occur in a proteinuric type 2 
diabetic patient ,the precise diagnosis of diabetic nephropathy requires 
histological evaluation  by renal biopsy.3 
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 While there is a strong concordance between diabetic nephropathy 
and retinopathy, in type 1 diabetes mellitus ,in type 2 diabetes the 
concordance is around 60 % as per studies done by Parving et al4 . Studies 
by J Prakash et al showed diabetic retinopathy not to be a good  predictor of 
diabetic nephropathy2.  In 50 % of those without retinopathy ,nephropathy 
was noted. Non diabetic renal lesions alone or coexisting with DN were 
noted in 40 % of those with retinopathy2 .  
 
 Hence we felt the need of a study to determine the concordance 
between diabetic nephropathy and retinopathy and to see the spectrum of 
non diabetic kidney diseases in proteinuric type 2 diabetics of our 
department . 
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AIMS AND OBJECTIVES 
 
• To study the concordance between diabetic nephropathy and 
retinopathy in patients of type 2 diabetes mellitus. 
 
• To study the clinical and lab profile of a patient with diabetic 
nephropathy Vs a patient with non diabetic nephropathy.  
 
• The spectrum of non diabetic renal disease in a proteinuric type 2 
diabetic . 
 
. 
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REVIEW OF LITERATURE 
 
 The prevalence of diabetes is high among Indians so studies on 
diabetic complications are important .3 
 
 Diabetic nephropathy and  retinopathy are two frequent complications 
of diabetes mellitus.1They progress to chronic kidney disease and loss of 
vision ,causing significant burden on the patient and health  system. 
Diabetic nephropathy is a syndrome comprising of  persistent proteinuria, 
hypertension and a low glomerular filtration rate (GFR).1 There is a  high 
risk of cardiac morbidity and mortality. This is seen in approximately 40% 
of type 2 diabetics.1  
 
 Retinopathy is an important complication of diabetes mellitus .It is a 
leading cause of blindness in adults.1 Diabetic retinopathy is primarily 
classified into non proliferative DR (NPDR) and proliferative DR (PDR).1 
Visual disturbance is in diabetic retinopathy is due to  macular edema and 
PDR. Vision loss can also occur due to vitreous haemorrhage from the new 
vessels in PDR.1 
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Overview of Diabetic nephropathy 
Historical facts – 
 Kimmelstiel and Wilson described the renal pathology of DN by 
autopsy as early as 1936. Eight cases were found to have the typical nodular 
glomerulosclerosis of diabetic nephropathy. These findings were confirmed 
by others also .Diffuse glomerulosclerosis was  described and differentiated 
from the nodular forms.5-6 
 
 Later studies involving percutaneous renal biopy and electron 
microscopy showed the earliest changes of diabetic nephropathy to be 
thickening of the basement membrane(GBM) and mesangial expansion.6 
 
Epidemiology 
 DN is well studied in patients with type 1 diabetes. The onset of 
disease is usually known in them.25% to 45% of these patients develop 
nephropathy in their lifespan.7 The peak time to develop nephropathy is 10 
to 15 years from onset.  In patients with type 2 diabetes, the prevalence of 
nephropathy is  reported to be lower. Nephropathy developed in 50% of 
type 2 diabetic Pima Indians.8 This was 20 years after diagnosis and 15% 
progressed to ESRD. Proteinuria is known to predispose for cardiovascular 
disease. It is thought that earlier studies underestimated the prevalence of 
DN. The actual prevalence of DN is difficult to determine ,as early 
cardiovascular mortality would have preceded the development of ESRD.  
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Recent data shows the risk of nephropathy to be same in both types of 
diabetes . The time to develop proteinuria from the onset and to progress to 
ESRD once proteinuria develops, were same in  types 1 and 2  diabetes.9 
 
Natural history of Diabetic nephropathy – 
 Mogensen et al proposed  five stages for renal involvement.10 
 
Stage 1: glomerular hyperfiltration. 
 Even with optimal blood glucose, GFR remains above normal in 25% 
to 40% of patients. In this group fall in GFR developed at a faster 
rate,compared to controls with normal GFR. This raised GFR is due to 
increased glomerular capillary filtration surface. Higher GFR early in the 
course of disease makes it more likely to develop DN.11 
 
Stage 2: Early lesions 
 Mild thickening of glomerular basement membrane takes place 18 to 
24 months from the start of type 1 diabetes.10 Glycosylation of the basement 
membrane causes an increase in filtration of proteins.The negative charge of 
the basement membrane is reduced which causes increased loss of albumin 
as it is no longer repelled by basement membrane.11 
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Stage 3: incipient diabetic nephropathy—stage of microalbuminuria. 
 Microalbuminuria is the urine albumin excretion of 20 to 200 g/min 
per day. It is associated with loss of renal function and  poor outcomes . 
Associated with vascular injury in other organs also.10 
 
Stage 4: clinical nephropathy—macroalbuminuria, decline in GFR . 
 Usually manifests in patients who have  diabetes for 15 to 20 years. 
Without intervention, the GFR in these patients, falls at about 1 
mL/min/month.  
 
Stage 5: End-stage renal disease- 
 ESRD occurs after 20 to 30 years of diabetes. This is seen in 30% to 
40%  with type 1 diabetes. Uremic symptoms and signs are seen at much 
higher creatinine clearances than nondiabetics.11 
 
Pathology - 
The 3 main pathological changes in the glomeruli of DN:  
(1) mesangial expansion.  
(2) glomerular basement membrane(GBM) thickening.  
(3) glomerular sclerosis.12   
 Glomerular sclerosis with a nodular appearance is called the 
‘‘Kimmelstiel-Wilson lesion’’. Hyaline deposits in the glomerular arterioles 
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reflects the leakage of proteins. These are namely fibrin, immunoglobulins, 
and complement .13 
 
 The mesangial expansion and glomerulosclerosis do not always 
develop together .This means that they have different pathogenetic 
mechanisms.12 Mesangial expansion is caused by hyperglycemia which 
causes an increased  formation or glycosylation of mesangial proteins.13 
 
Pathogenesis of Diabetic nephropathy- 
Factors involved - 
• Hemodynamic pathways 
• Hyperglycemia and Advanced glcosylation end products 
• Protein kinase C pathways 
• Aldose reductase pathways 
• Prorenin 
• Cytokines 
• Oxidative stress 
• Genetic susceptibility 
 
Hemodynamic factors – 
 Glomerular  hyperfiltration is because of decreased resistance in both 
the afferent and efferent arterioles.The afferent arteriole has lesser resistance 
than the efferent.12 Factors involved in this defective autoregulation are 
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prostanoids,nitric oxide,vascular endothelial growth factor VEGF. TGF-β1, 
and the renin–angiotensin system mainly angiotensin II are the other factors 
mainly seen.13 The hemodynamic factors result in albumin to leak from the 
glomerular capillaries. Increased production of mesangial cells, thickening 
of the GBM and injury to podocytes are due to hemodynamic factors. 
Glomerular hypertension and hyperfiltration play an important role in the 
pathogenesis diabetic nephropathy as use of angiotensin blockers prevents 
loss of nephrons. Blocking  the angiotensin system prevents the fibrosis 
inducing effects of angiotensin II on TGF -β.15 
 
Hyperglycemia and advanced glycosylation end products 
 Hyperglycemia causes an increase in mesangial cell proliferation and 
hypertrophy.16 Hyperglycemia is associated with an  increased matrix 
production and basement membrane thickening. Mesangial cell expansion is 
due to an increase in the mesangial cell glucose concentration.17 
Hyperglycemia causes the upregulation of VEGF expression in 
podocytes.This markedly increases vascular permeability.18 
 
Advanced glycosylation end products 
 Glycosylation of  proteins is one of the causes of   nephropathy. Long 
standing increased sugars, causes glucose to combine with free amino acids 
on  tissues.17 This nonenzymatic process has an affect on the glomerular 
basement membrane18.Other matrix components in the glomerulus are also 
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affected.The early formation of reversible glycation products are replaced 
later by irreversible advanced glycation products. The levels of AGE are 
increased in the diabetics. This is more in renal failure,as it is excreted in the 
urine.18 This leads to accumulation of advanced glycosylation end products 
which  has a tendency to cross-link with collagen. This contributes to 
development of DN. 
 
Protein kinase C 
 Hyperglycemia causes  diabetic nephropathy by activation of PKC. 
Activation of this enzyme causes the increased production of  prostanoids 
which cause vasodilatation.This contributes to glomerular hyperfiltration. 
PKC activation causes the formation of diacylglycerol which leads to 
oxidative stress.19  PKC activation also increases the activity of mitogen-
activated protein kinases (MAPK). 
 
Aldose reductase pathway 
 This enzyme helps in changing sugars into alcohols. By this enzyme 
glucose is converted into sorbitol and galactose  into galactitol.These 
alcohols ,fail to diffuse out from the cells .Their accumulation intracellularly 
causes osmosis thereby allowing entry of water into the cell.20This results in 
electrolyte imbalances and  also the depletion of myoinositol. This causes 
tissue damage to occur.21 
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Prorenin 
 Increased prorenin activity in the plasma was found to be a risk factor 
for the development of diabetic nephropathy.21 The prorenin receptors are 
located in the mesangium and podocytes of the kidney. Prorenin binding to 
specific tissue receptors  promotes the activation of p44/p42 MAPK.22 The 
blocking of  Prorenin receptors prevented MAPK activation which blocked 
nephropathy from progressing . 
 
Cytokines  
 Activation of cytokines, enzymes causing  profibrosis, inflammation 
and VEGF are some of the factors involved in increased matrix formation in 
diabetic nephropathy.23 Hyperglycemia increases VEGF expression acts to 
cause endothelial injury in diabetes.22 
 
 The VEGF and angiopoetin cause vessel leakage of proteins .These 
two  factors play important roles in development of retinopathy and  
nephropathy. VEGF  stimulates the formation of α3 chain of collagen which 
is an important component of the GBM. It is seen that increased formation 
of collagen leads to the thickening of the GBM.22 
 
 Some studies however do not show VEGF as a causative factor , 
Baelde et al demonstrated  VEGF mRNA levels,to be low in the glomeruli 
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for some cases of diabetic nephropathy.This was associated with reductions 
in  podocytes number and development of nephropathy.24 
 
 Hyperglycemia can increase the production of TGF-β1 in the 
glomeruli.21 
 
 Inflammatory cytokines are responsible for the progression of 
diabetic nephropathy.They are interleukins 1,6,8 (IL‑1,6,8) and tumor 
necrosis factor.Increased levels of interleukins correlate well with 
development of nephropathy. IL-1 acts on chemotactic factors and adhesion 
molecules altering their expression. It also causes intraglomerular 
hypertension. Increases vascular endothelial permeability. It also has an 
effect to increase hyaluron production by renal tubular epithelial cells.22 IL-
6 acts likely by increasing  the glomerular basement membrane thickening. 
It also has a possible role to increase endothelial permeability and mesangial  
proliferation. IL-18 increases the production of other inflammatory 
cytokines. 
 
Oxidative stress 
 Reactive oxygen species are produced in the nephrons during cellular 
metabolism. These molecules are countered by a large number of 
antioxidants and free radical scavengers. Reactive oxygen species have 
negative  effects. They cause peroxidation of cell membranes lipids.They 
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also cause renal vasoconstriction. Hyperglycemia shifts the balance towards 
formation of reactive oxygen species.Most of these are generated in the 
mitochondria.21.Concentrations of the reactive oxygen species are higher in 
those with more severe nephropathy. 
 
Genetic susceptibility 
 As mentioned earlier increased production of angiotensin II 
determines the initiation and progression of DN. Angiotensin II mainly acts 
by affecting hemodynamic and nonhemodynamic mechanisms.24 
Polymorphism of the ACE gene  due to inversion or deletion (ACE/ID) 
occurs. This is associated with varying levels of circulating ACE. The 
probability of developing DN is more for patients,having a sibling or parent 
with history of DN. Patients with DD polymorphism of the ACE gene have 
a high risk of developing diabetic nephropathy and progressive renal failure. 
 
Clinical predictors and risk factors for diabetic nephropathy and 
Retinopathy 
1)Glycemic control 
 Diabetic nephropathy develops more often in patients with long 
standing uncontrolled hyperglycemia. Diabetics with a hemoglobin A1c 
level less than 8.1% are at much lower risk for DN25.Randomized clinical 
trials have confirmed this association both for nephropathy and retinopathy. 
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The United Kingdom Prospective Diabetes Study (UKPDS)in type 2 
diabetics,showed fewer patients of the tight blood sugar control to progress 
to microalbuminuria. Less in the intensive blood sugar group compared to  
conventional group progressed to microalbuminuria (27% versus 39%) and 
proteinuria (7% versus 13%)over a 15 year followup period26. The Diabetes 
Control and Complications Trial (DCCT) highlighted the benefits of 
intensive therapy for glycemic control. They showed a reduction in  
microalbuminuria by 39% and albuminuria by 54%  respectively27.The 
DCCT showed that in the intensive arm there was a  76% reduction in the 
development of retinopathy28.Even in those with established retinopathy 
there was a 80% reduction in progression,compared to  those with 
conventional control. These targets were achieved by maintaining a median 
hemoglobin A1c level of 9.1% and 7.3 % in the conventional and intensive 
treatment group respectively28.These benefits persisted even after 7 years of 
continued follow-up. This finding was demonstrated by Epidemiology of 
Diabetes Interventions and Complications study. The difference in HbA1c 
levels between  two  groups was  0.4% .Though this diference appears small 
it still  provided benefit I year after completion of the DCCT. Wisconsin  
study of DR was a population based study. This study was done to 
determine the prevalence and severity of DR in their study population. The 
study concluded that there is a strong association between severity of 
retinopathy and high levels of HBA1C.27 
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 For patients with already existing advanced retinopathy, strict  control 
of blood glucose will not be helpful in preventing the progression of 
retinopathy.27 
 
2)Duration of disease 
 The total duration of disease was found to be an important risk factor 
for the development and progression of retinopathy26.The Wisconsin 
epidemiologic study of retinopathy, showed that the longer the duration of 
diabetes more the prevalence of retinopathy in the study population .27 
 
3) Blood pressure - 
 Studies show  increased systolic blood pressure to be a strong risk 
factor for both diabetic nephropathy and retinopathy. This risk was  more 
for retinopathy26. In UKPDS trial it was seen that good blood pressure 
control led to decreased progression of retinopathy. A 10/5 reduction of 
blood pressure  caused a 34% reduction in progression of retinopathy and  
47% decreased risk of deterioration in visual acuity.27 
 
4)Glomerular filtration rate – 
 Patients with glomerular hyperfiltration had an increased risk for 
developing diabetic  nephropathy .The glomerular hyperfiltration and 
hypertrophy are due to intraglomerular hypertension and capillary wall 
stress.29 
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 In type 2 diabetes , 45% have a GFR that is significantly more than 
age matched nondiabetics and obese controls  The amount of hyperfiltration  
is lesser in type 2 diabetics compared to type 1. Type 2 diabetics being older 
are more likely to have atherosclerotic vascular disease,this factor probably 
limits the increase in glomerular filtration.30 
 
Diabetic Retinopathy 
Natural history and classification 
 In the early stages of diabetic retinopathy there is loss of pericytes 
near the capillaries of the retina. This causes weakness in the walls of the 
capillaries.31 Microaneurysm develop as a result of this weakness.The 
increased permeability of the capillaries cause them to leak fluid . This 
capillary wall weakness, causes impaired  function of the blood vessels ,this 
gradually leads to areas of ischemia and infarction.32 These changes cause 
local growth factors to be produced leading to new vessel proliferation. 
 
Classification of diabetic retinopathy 
1) Non proliferative diabetic retinopathy- characterised by 
microaneurysms,hemorrhages and exudates .This does not affect 
vision.33 
2) Retinopathy with maculopathy- characterised by macular edema  
causing vision to be affected . 
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3) Proliferative diabetic retinopathy – characterised by 
neovascularisation ,fibrous proliferation and vitreous haemorrhages 
which can lead to sudden loss of vision.34 
4) Advanced diabetic eye disease –which leads to vitreous 
opacities,hemorrhages and retinal detachment . 
 
Pathology and pathogenesis of diabetic retinopathy 
 In nonproliferative DR the main features are structural abnormalities 
of the retinal vessels. Mainly the capillaries are involved, although venules 
and arterioles are also frequently  involved. This causes retinal ischemia, 
edema and haemorrhages.33 Proliferative DR has the previously mentioned 
changes, in addition features like optic disc, retinal or iris 
neovascularization. Retinal neovascularization e vitreous haemorrhages. 
Vascular endothelial growth factor (VEGF) is a powerful stimulator of 
vasculogenesis  and mitogenesis.33  Increased VEGF levels are present in 
the retina of diabetic patients.34 As mentioned previously they act by 
increasing the vessel permeability ,causing  increased amounts of vascular 
leakage.34 
 
 Apoptosis of retinal capillary pericytes  and, to a smaller extent the 
retinal capillary endothelial cells occur.This has been shown in early DR35. 
Pericyte glutathione  defends against peroxidation. High glucose states lead 
to their depletion36. This high concentration of glucose serves as an 
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apoptotic  signal for retinal pericytes. The apoptosis that occurs leads to a 
series of events that first result in NP DR. As the loss of pericytes and 
damage to endothelial cells progresses, there is a release of  transforming 
growth factor [TGF]-b) . As mentioned earlier, aldose reductase which acts 
by converting sugars into their respective alcohols, is found in high 
concentrations in retinal pericytes causing damage to it.36 
 
Relation between diabetic nephropathy and retinopathy – 
 Patients with type 1 diabetes and nephropathy usually have other   
microvascular diseases, like retinopathy and neuropathy. Advanced 
retinopathy  occurrance indicates histologic changes of DN in the glomeruli 
also .There is increased protein loss in urine of at least the microalbuminuric 
range.37 
 
 The relationship between diabetic nephropathy and retinopathy is less 
reliable in type 2 diabetes. One study with 35 patients of diabetes and 
significant proteinuria (>300 mg/d), 27 (77%) had diabetic nephropathy.4 
Retinopathy  presented in 15 (56%) of the 27 with DN and in none of the 8  
without DN. This gave retinopathy  a sensitivity and specificity of 40% and 
100% respectively.5 
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 Type 2 diabetics with significant proteinuria and retinopathy are most 
likely have DN, but in those without retinopathy there is a higher incidence 
of nondiabetic glomerular disease .5 
 
Diagnosis of diabetic nephropathy – 
 The techniques available for detecting diabetic nephropathy are the 
albumin : creatinine ratio or a protein:creatinine ratio from a random spot 
urine or a 24-hour urine collection37 . Positive results need a second 
measurement to reconfirm. In diabetics protein excretion  varies 
considerably. Urine dipsticks for microalbuminuria (on fresh morning 
specimens) are used only for initial screening. A positive tests should be 
followed-up by a 24-hour urine collection.38 Microalbuminuria is defined as 
the urine protein : creatinine ratio of 30- 300 mg/g and macroalbuminuria is 
defined as a protein : creatinine ratio > 300 mg/g in a spot or 24 hours timed 
specimen . Short-term hyperglycemia, exercise, urinary tract infections, 
marked hypertension,heart failure, and acute febrile illness can cause 
transient elevations in urinary albumin excretion38. As there is a marked 
variability in the day to day excretion of albumin,at least 3 samples are 
required over a 3 month period ,before confirming the presence of 
microalbuminuria .36 
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Diagnosis of diabetic retinopathy 
 Early detection of diabetic retinopathy is essential .Photocoagulation 
therapy is more effective when applied to earlier stages of DR .Hence 
guidelines are required for the screening of patients ,so that retinopathy can 
be detected early.38 
 
 Current guidelines suggest that newly detected diabetics ,should 
undergo a fundus evaluation by an ophthalmologist soon after diagnosis of 
type 2 diabetes mellitus .The fundus examination should be done after full 
dilation of the pupils ,to visualise lesions even in the periphery of the retina . 
 
Fundus findings 
1.  No retinopathy  - 
 No microvascular lesions. 
2.  Mild non-proliferative diabetic retinopathy (NPDR) 
 Microaneurysms are main findings . 5% and 14% of patients progress 
to proliferative diabetic retinopathy in 1 year and 3 years respectively . 
 
3.  Moderate NPDR – 
 Microaneurysms along with other microvascular lesions are seen.12–
26% (within 1 year) and 30–48% (within 3 years) progress to proliferative 
diabetic retinopathy.38 
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4.  Severe NPDR  
 Characterised by more than 20 intraretinal haemorrhages in four 
quadrants.Venous beading in two or more quadrants, or intraretinal 
microvascular abnormalities in one or more quadrant but not proliferative 
diabetic retinopathy. 52% (within 1 year) and 71% (within 3 years) progress 
to proliferative diabetic retinopathy.39 
 
5.  Proliferative diabetic retinopathy- 
 The findings noted are neovascularisation of optic disc (NVD) or 
elsewhere (NVE).Preretinal haemorrhages or vitreous haemorrhages.High 
risk characteristics are seen in those with vitreous haemorrhage irrespective 
of the degree of neovascularisation. Moderate NVE with vitreous 
haemorrhage is an indication for panretinal photocoagulation.38 
 
6. Clinically significant macular oedema - 
 Retinal thickening within 500 µm from centre of macula, hard 
exudates within 500 µm from centre of macula associated with adjacent 
retinal thickening. Retinal thickening of more than one optic disc area or 
within one optic disc diameter from centre of macula are considered 
characteristic of macular edema .40 
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(A) (B) 
 
 
 
(E) (F) (G) 
 
 
 
 
Fig A and B- denotes microaneurysms, haemorrhages and hard exudates . 
Fig C – denotes intraretinal microvascular abnormalities(IRMA) 
Fig D – denotes venous beading .  
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MATERIALS AND METHODS 
Study type 
 Prospective study. 
 
Sample size 
 157 cases 
 
Inclusion criteria-  
 Patients with Type 2 Diabetes mellitus are included. 
 
Exclusion criteria- 
 Type 1 Diabetics, known cases of nephrotic syndrome, active upper 
or lower urinary tract infections and chronic kidney disease.  
 
Study Methods- 
1. Diabetics were defined according to the American Diabetes 
association guidelines  
a. Fasting blood glucose >126 mg/dl, symptoms of 
hyperglycemia with a random blood glucose >200 mg/dl . 
b. Impaired fasting glucose defined as glucose between 100-126 
mg/dl and a positive glucose tolerance test showing a 2 hours 
post prandial blood sugar >200 mg/dl are included. 
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2. Type 2 diabetics defined as patients on diet therapy or oral 
hypoglycemic agents for control of sugars. If on insulin therapy 
,should have onset of diabetes after the age of 40 years ,with body 
weight excess than ideal at time of diagnosis. 
3. Urine analysis and protein creatinine ratio of urine were obtained. 
Urine protein creatinine ratio to be confirmed on at least 3 urine 
samples. 
4. If urinary tract infection is present ,treated according to urine culture 
report and then the proteinuria to be reassessed . 
5. All diabetics are screened for retinopathy using direct opthalmoscopy 
by an ophthalmologist and graded according to the Early Treatment 
Diabetic retinopathy study. Fundus Fluorescein angiography (FFA) is 
to be done on those patients with evidence of diabetic retinopathy . 
6. For all patients included in the study,serum creatinine estimation to 
be done, and the estimated GFR calculated using modified MDRD 
equation . 
7.  Renal biopsy was done in those patients who had, 
i. Absence of diabetic retinopathy . 
ii. Rapid decline of GFR . 
iii. Nephrotic range proteinuria with a normal GFR . 
iv. Active urinary sediments . 
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 Renal biopsy was done after obtaining an informed written consent.  
 
 Biopsies were interpreted by a single pathologist under light 
microscopy using hematoxylin and eosin and periodic acid Schiff(PAS) 
staining . 
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RESULTS 
 
Total number of Type 2 diabetics studied – 157 
Sex distribution - 
Males comprised of 118 patients (75%) of the study group. 
Females comprised of 39 patients(25%) 
 
 
 
 
 
  
118(75%)
39(25%)
Numbers
Males
Females
27 
 
 
Age distribution  
 
 
Age distribution frequency –  
Age range(years) Numbers Percentage % 
21-30 5 3 
31-40 17 10.8 
41-50 45 28.7 
51-60 57 36 
61-70 29 18.5 
71-80 4 2.5 
 
 The age in the study population ranged from 26 to 78 years ,with a 
mean age of 52 years with a SD of 10 years . 
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Duration of diabetes – 
 
 
 In a majority of patients duration of diabetes was between 2 to 5 years 
comprising  53 %. 
 Duration was less than 2 years in 20 % and more than 10 years in 
12% . 
 The least duration of diabetes in the study group was 2 months ,and 
the maximum duration was of 25 years . 
 The mean duration of diabetes was 5.59 years with a SD ±5.1 . 
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Hypertensive profile
 Total of number of patients with hypertension = 115
 Total number without hypertension =42
 Profile of Hypertension
The mean duration of hypertension was 1.9 years with a standard deviation 
of 2.9 years . 
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BMI of the study population 
13(8%) were underweight with a BMI less than 18 .
24(15%) were overweight with a BMI of more than 25 .
The BMI ranged from 16 to 30 ,with a mean BMI of 22.1 and a 
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GFR profile – 
 
For all patients in the study group GFR was measured using 
MDRD equation . 
The GFR ranges from 5 ml/min to 86 ml/min .
Mean GFR is 29 ml/min with a 
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 Profile of diabetic microvascular complications
- Nephropathy (proteinuria) 
- Retinopathy 
- Neuropathy 
 
Profile of Proteinuria 
All the diabetics in the study population had proteinuria .
Urine protein creatinine ratio (PCR) was done .
The PCR ranged from 0.3 g/mg 
and a standard deviation of 2.0 g/mg .
 
PCR FREQUENCY CURVE
 Urine analysis showed an active sediment with RBC or RBC casts in 
6 out of the 157 patients.
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 Profile of Retinopathy
 
140 patients in the study group had evidence of diabetic retinopathy .
Non proliferative diabetic retinopathy(NPDR) was seen in 121
Proliferative diabetic retinopathy(PDR) was seen in 19 .
In 94 of the 140 patients ,retinopathy was confirmed by fundus fluorescein 
angiography (FFA) 
20 patients underwent panretinal photocoagulation (PRPP). 
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ASSOCIATION BETWEEN RETINOPATHY AND PROTEINURIA- 
 
 The association between retinopathy and the quantum of proteinuria 
using urine PCR was analysed . 
 
Retinopathy Urine  Protein Creatinine Ratio (PCR) mg/g 
0.5 - 1 1.1-3.5 3.6-5 >5 
Yes 9.3 % 47.9% 17.9% 25% 
No 0 52.9% 41 % 6% 
   p=0.04 
 
 Analysis showed 25 % of patients with diabetic retinopathy had a 
quantum of proteinuria (PCR) > 5 mg/g ,whereas in the non diabetic 
retinopathy group only 6 % had this quantum of proteinuria. 
 
This difference was statistically significant (p value =0.04) 
 
ASSOCIATION BETWEEN DIABETIC RETINOPATHY AND 
HYPERTENSION – 
We analysed the study population to see if retinopathy was more common in 
t patient having co existing hypertension as well . 
 Hypertension 
Retinopathy Yes No 
Yes 103 (73%) 37(26 %) 
No 10 (58%) 7 (42 %) 
p =0.2 
 73 % of the patients with retinopathy, had coexisting hypertension also 
compared to 26%  with retinopathy who did not have hypertension .
 
This difference however was not statistically significant (p=0.2)
 
Profile of neuropathy 
 Diabetic peripheral neuropathy was seen in 32 patients (20 %) of the 
study population . 
Profile of macrovascular diabetic complication
 Ischaemic heart disease 
 Ischaemic heart disease in the form of left ventricular dysfunction 
was seen in 28 patients (17%) of the study group .
 
35 
– 
 – 
 
 
 
32
125
28
129
 
 
 
 
YES
NO
YES
NO
36 
 
Profile of renal biopsy- 
 Renal biopsy was done in 32 patients(20.4%) of the study population 
based upon the indications for renal biopsy as mentioned in the study 
protocol . 
 The biopsies (n=32) showed  
 Diabetic nephropathy(DN)                                    -   19 (59 %) 
 Non diabetic nephropathy (Non DN)                    -    11 (34%) 
 Non diabetic nephropathy superimposed on DN   -       2 (6 %) 
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Spectrum of non diabetic nephropathy – 
Pathology Frequency 
Membranous Nephropathy 2 
MCD/FSGS 2 
Crescenteric glomerulonephritis 1 
Anti –GBM disease 1 
Acute tubular necrosis (ATN) 1 
Chronic interstitial nephritis (CIN) 1 
Glomerulosclerosis 2 
 
 The patterns of non diabetic kidney disease superimposed on diabetic 
nephropathy (n=2) were  
 
- Infection related glomerulonephritis (IRGN) with diabetic 
nephropathy . 
- Henoch Scholein purpura (HSP) with diabetic nephropathy . 
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Pathological features of diabetic nephropathy – 
The pathological features of diabetic nephropathy noted on renal biopsy 
were , 
Pathology Frequency(n=19) 
Mesangial expansion 18 
Diffuse glomerulosclerosis 10(53%) 
Nodular glomerulosclerosis 6(32%) 
Hyalinosis of Efferent artery 5(26%) 
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Analysis of risk factors for diabetic nephropathy– 
 The risk factors for the cases of biopsy proven diabetic nephropathy 
were analysed. 
 
Risk factors analysed are - 
1. Duration of diabetes. 
2. Patient age 
3. Quantum of proteinuria  
4. Hypertension  
5. BMI 
6. Esimated GFR(eGFR) 
7. Serum cholesterol  
 
Relation between duration of diabetes and diabetic nephropathy - 
 The prevalence of diabetic nephropathy based on the duration of 
diabetes was analysed .The duration of diabetes in the diabetic nephropathy 
and non diabetic nephropathy group was as follows . 
 
Duration (yrs) DN (n=19) Non DN (n=11) DN + nonDN     (n=2) 
< 2 3(15%) 3(27 %) 0 
2- 5 8(42%) 7(63%) 1 
6- 10 7(36%) 1 (9%) 0 
>10 3( 5%) 0 1 
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Graphical representation of duration of diabetes in diabetic nephropathy Vs 
non diabetic nephropathy . 
 
 
 
 The statistical analysis of duration of diabetes as a risk factor for 
diabetic nephropathy was done by a  Chi Squared test .The analysis showed 
that duration of diabetes was not a statistically significant risk factor ( p 
value 0.8). 
 
 Thus in our study, duration of diabetes was not a predictor of diabetic 
nephropathy . 
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2. Relation between patient age and nephropathy – 
 The age group of 61 – 70 years comprised the largest group of 
patients with diabetic nephropathy(n=19) in the study ,8 patients  (42 %) 
were in this group,followed by the age group of 51 – 60 years comprising 5 
patients (26 %) .The age groups (31 – 40) and (41 – 50) comprised of 10 % 
and 15 % of the study population respectively . 
 
Relation between patient age and non diabetic nephropathy – 
 In the non diabetic nephropathy group(n=11) ,the age group 41 – 50 
years was the most common, comprising 5 patients (45.5%).The age groups 
51 – 60 yrs and 61 – 70 years comprised 18 % each respectively. 
 
Comparision of patient age as a risk factor in the DN vs non DN 
groups. 
 Analysis using the chi squared test ,showed that age is not a 
statistically significant risk factor for the development of diabetic 
nephropathy (p =0.7) 
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Relation between proteinuria and diabetic nephropathy – 
 Urine protein estimation was done using the spot urine protein 
creatinine ratio (urine PCR) .The quantum of proteinuria and its relation 
with diabetic nephropathy was analysed . 
 
Urine PCR 
(g/mg) DN (n=19) Non DN (n=11) 
DN + non DN 
(n=2) 
1.1 – 3.5 12 (63%) 6 (55%) 1 
3.6 – 5 6 (31%) 4 (36%) 0 
> 5 1 (5%) 1(5%) 1 
 
2
3
5
9
1
5
2
3
0 0
1 1
0
1
2
3
4
5
6
7
8
9
10
31 - 40 yrs 41 - 50 yrs 51 - 60 yrs 61 - 70 yrs
DN
non DN
DN + non DN
43 
 
 
 
Comparison of quantum of proteinuria in diabetic nephropathy vs non 
diabetic nephropathy – 
 
 The quantum of proteinuria was compared in the diabetic 
nephropathy vs non diabetic nephropathy group . 
 
 Statistical analysis using the Chi Squared test ,showed the p value to 
be 0.3 which was not statistically significant. 
 
 We were unable to differentiate diabetic nephropathy from non 
diabetic nephropathy based on the quantum of proteinuria in our study . 
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Relation between Hypertension and diabetic nephropathy – 
 The presence and duration of hypertension were analysed as risk 
factors for diabetic nephropathy . The prevalence and duration of 
hypertension in the diabetic vs non diabetic nephropathy group were 
analysed. 
 
The prevalence of hypertension was as follows  
Hypertension DN (n=19) Non DN (n=11) DN + non DN 
Yes 13 (68 %) 6(55 %) 1 
No 6( 32 %) 5(45%) 1 
 
Hypertension profile- 
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Analysis of duration of hypertension – 
The analysis of duration of hypertension showed the following data  
HTN duration DN(n=19) Non DN(n=11) DN + non DN (n=2) 
< 2 yrs 6(31 %) 5(45 %) 1 
2 – 5 yrs 3(16%) 0 0 
6 – 10 yrs 1(5%) 0 0 
>10 yrs 1(5%) 0 1 
 
Graphical representation- 
 
 
Analysis of hypertension as a risk factor for diabetic nephropathy – 
 
 The statistical analysis of  hypertension as  a risk factor for diabetic 
nephropathy was done using the Chi Squared test. 
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 The result showed that hypertension and its duration were not 
statistically significant risk factors with a p value of 0.7 and 0.19 
respectively . 
 
Analysis of BMI as a risk factor for nephropathy – 
 The BMI profile for the patients in the DN vs non DN group was 
follows . 
BMI DN Non DN 
Underweight( BMI<18) 1(5.3%) 1(9 %) 
Normal (19 -24) 18 (94.7 %) 10 (91%) 
Overweight( >25) 0 0 
p value=0.85 
 There was no significant difference in BMI between the DN and non 
DN group in the study (p value 0.85). 
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Estimated GFR(eGFR) comparision between DN vs non DN group – 
 GFR estimation was done in diabetic nephropathy (DN) and non 
diabetic nephropathy (NDN) group using the modified MDRD equation. 
 
The following results were noted  
eGFR(ml/mt) DN(n=19) Non DN(n=11) DN +non DN(n=2 
45 - 59 8(42%) 3 (27%) 0 
30 - 44 9(47%) 4(36%) 2(13%) 
16-29 1( 5%) 3(27%) 0 
<15 1(5%) 1(9%) 0 
p=0.4 
 
 There was no statistical difference in eGFR between the DN and non 
DN group (p value 0.4). 
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Comparision of cholesterol profile in the DN Vs Non DN group – 
 The serum cholesterol levels in diabetic nephropathy and non diabetic 
nephropathy group were as follows . 
 
Cholesterol profile- 
Group Mean 
cholesterol(mg/dl) Range(mg/dl) 
DN 160 110-234 
Non DN 138 118-186 
DN + non DN 123 120-126 
p = 0.19 
 
 Though the mean serum cholesterol levels were higher in DN group 
compared to the non DN group ,this difference was not statistically 
significant (p=0.19) 
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Concordance of diabetic retinopathy and diabetic nephropathy – 
 The presence of diabetic retinopathy was evaluated in the diabetic 
nephropathy(DN), non diabetic nephropathy(NDN) and the NDN 
superimposed on DN group . 
 
The results in each group were as follows . 
Diabetic 
retinopathy 
DN 
(n=19) 
NDN 
(n=11) 
DN + NDN 
(n=2) 
Yes 10(53%) 4(36%) 1 
No 9(47%) 7(63%) 1 
 
Total num. of patients with biopsy proven diabetic nephropathy -  21 
Total num .with retinopathy in this group    -  11 
Percentage with diabetic nephropathy having retinopathy      -  54% 
Percentage without diabetic nephropathy having retinopathy - 36 % 
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Graphical representation of diabetic retinopathy in DN vs NDN groups- 
 
 
 
 Statistical analysis by Chi Squared testing showed that even though 
retinopathy was seen in 53 % of patients with diabetic nephropathy and in 
only 36 % of patients with non diabetic nephropathy ,this difference was not 
statistically significant (p value 0.6 ). 
 
 Sensitivity of retinopathy for diabetic nephropathy is 71.4% 
 Specificity of retinopathy is 63.6 % 
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DISCUSSION 
 Type 2 diabetes is a global epidemic with an increasing incidence 
over the last decade. Diabetic nephropathy (DN) occurs in approximately 
one third of the patients with type 2 diabetes and contributes greatly to its 
morbidity ,mortality and cost of treatment. 
 
 It is diagnosed clinically by persistant proteinuria (>500 mg/day), 
hypertension and the presence of diabetic retinopathy in a patient with 
diabetes of long standing duration. 
 
 In addition to classical diabetic nephropathy ,diabetic patients can 
also develop primary or secondary glomerular diseases unrelated to diabetes 
(NDN). There exists a third group of patients also who can have a NDN 
superimposed on a background of DN. 
 
 We suspect a NDN when a diabetic presents with overt proteinuria 
with duration of diabetes being less than 5 years, a rapid decline in renal 
function, impaired renal function in the absence of significant 
proteinuria,active urinary sediment or the absence of diabetic retinopathy. 
 
 The presence of diabetic retinopathy while correlating well with 
diabetic nephropathy in type 1 diabetics ,the concordance in type 2 diabetics 
is only around 60 % as demonstrated in the study by Parving4 et al 
published in 1992.Study by Prakash3 et al published in 2007 showed 
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retinopathy to be a poor predictor of diabetic nephropathy as 50 % of the 
renal biopsy proven diabetic nephropathy patients  in their study lacked 
retinopathy. 
 
 This background led us to our present study ,were we studied the 
concordance between diabetic nephropathy and retinopathy, the clinical and 
lab profile of a patient with diabetic nephropathy Vs a patient with non 
diabetic nephropathy and the spectrum of non diabetic renal diasease in a 
proteinuric type 2 diabetic . 
 
 In our study we analysed 157 proteinuric type 2 diabetics .The study 
population comprised of 118 males (75 %) and 39 females (25 %) ,with a 
male to female ratio of 3:1. The male predominance in proteinuric diabetic 
patients has also been documented in the study by Parving4 et al which 
showed a male to female ratio of 4:1 . 
 
 The age group of the study population ranged from 26 years to 78 
years with a mean age of 52 years .Majority of the patients were in the age 
group of 51 – 60 years comprising of 57 patients (36 %) followed by the age 
group 41 to 50 years which had 45 patients (28 %) . The study by J Prakash3 
et al analysing diabetic retinopathy as a predictor of nephropathy ,showed 
an age range of 30 – 78 years with a mean age of 54 years, comparable to 
our study. 
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 Analysis of the duration of diabetes showed ,the duration to range 
from a minimum of 2 months to a maximum duration of 25 years .The mean 
duration was 5.59 years with a standard deviation of 5.1 years .In a majority 
the duration of diabetes was between 2 to 5 years comprising 82 patients(53 
%).The Parving study has not evaluated the duration of diabetes while the J 
Prakaash study showed a mean duration of diabetes of 10 years with a range 
from 4 months to 25 years .The mean duration of diabetes was substantially 
lower in our study. 
 
 Another study by Teresa Wong40 et al showing the profile of 
proteinuric diabetics with and without diabetic nephropathy showed a mean 
duration of diabetes of 8 years in their study. 
 
 In our study group 115 patients (73 %) had coexisting hypertension as 
well.The mean duration of hypertension was 1.9 years +/- 2.9 years . In a 
majority 86 patients (56 %) the duration of hypertension was less than 2 
years .J Prakash et al study showed a hypertension prevalence of 47.8% in 
their study group .In the Teresa40 et al study the prevalence of hypertension 
was 87 % which was comparable with our study . Dakshinamoorthy41 et al 
study of non diabetic kidney disease in a proteinuric type 2 diabetic, showed 
a prevalence of hypertension of 84 % in their study. 
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 The nutrition status of our study population was assessed by body 
mass index measurements (BMI) .The mean BMI was 22.1 (range from 16 
to 30).13 patients (8 %) had a BMI less than 18 and were classified as 
underweight .24 patients had a BMI of more than 25 and were classified as 
overweight .Teresa40 et al showed a mean BMI of 24.9 in their study group.   
 
 For all our patients we estimated the glomerular filtration rate (GFR) 
using the modified MDRD equation .The mean GFR was 29 ml/min with a 
standard deviation of 15 ml/min. GFR range was from 5 – 86 ml/min .In the 
Teresa40 et al study the mean serum creatinine values were 167 ± 100 
µmoles, GFR estimations were not done. The mean serum creatinine in the 
Dakshinamoorthy41 et al study was 4.3 mg/dl ± 3.9 mg/dl. 
 
 The quantum of proteinuria in the study group was determined by 
urine protein creatinine ratio (PCR).The urine PCR ranged from 0.3 g/mg to 
8.1 g/mg ,with mean PCR of 3.6 g/mg .The mean quantum of proteinuria in 
the Dakshinamoorthy study was 4.2 gram/day and was 2 gram/day in the 
Theresa et al study. 
 
 The presence of diabetic retinopathy was determined for all patients 
in the study population. 140 patients(89 %) had diabetic retinopathy . Non 
proliferative diabetic retinopathy was seen in 121 patients (86 %) 
.Proliferative diabetic retinopathy was seen in 19 patients (14 %).In 94 of 
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the 140 patients retinopathy was confirmed by fundus fluorescein  
angiography(FFA). 
 
 20 patients underwent pan retinal photocoagulation (PRPP) for 
proliferative diabetic retinopathy .In a study by Trevisan47 et al in 2002 
evaluating the effect of retinopathy and concomitant proteinuria in a  
diabetic patient, showed 55 % of the proteinuric(>500 mg/day) diabetics to 
have retinopathy .In their cohort 52 % had proliferative diabetic retinopathy 
and 48 % non proliferative diabetic retinopathy .We analysed the 
association between retinopathy and quantum of proteinuria .We found that 
25 % of patients with retinopathy had a urine PCR>5 g/mg while only 6 % 
without retinopathy had this quantum of proteinuria .This difference in PCR 
between the two groups was found to be statistically significant .Trevisan47 
study also found a difference in proteinuria (1.9 g/day vs 0.8 g/day) between 
the retinopathy and non retinopathy group though not statistically 
significant. 
 
 Hypertension as a risk factor for retinopathy was analysed in our 
study,showed that 73 %  patients with retinopathy had coexisting 
hypertension also, but this relation was found not be statistically significant. 
Trevisan et al also found this association not to be statistically significant. 
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 Evaluation for other microvascular and macrovascular complications 
of diabetes showed presence of peripheral neuropathy in 32 patients (20 %) 
and ishaemic heart disease presenting as LV dysfunction in 28 patients (17 
%). 
 
 Renal biopsies were done in 32 patient (20 %) of the study population 
based on the biopsy protocol of our study .The biopsy results showed 
diabetic nephropathy(DN) to be present in 19 patients (59 %) of the total 
number of 32. 
 
 Non diabetic nephropathy (NDN) was seen in 11(34%) patients and 
non diabetic nephropathy superimposed on a background of diabetic 
nephropathy(NDN +DN) was seen in 2 patients(6%). 
 
 The non diabetic nephropathies (NDN=11) seen in the study group 
were membranous nephropathy (2),focal segmental glomerulosclerosis 
(FSGS) in (2), cresenteric glomerlonephritis(1) and anti GBM disease(1) , 
tubulointerstitial nephritis ATIN (1) and CTIN(2) and finally global 
glomerulosclerosis (with no evidence of DN ) suggestive of chronic kidney 
disease in (2). 
 
 The patterns of non diabetic nephropathies(NDN) superimposed on 
DN, (NDN+DN =2) were Infection related glomerulonephritis(IRGN) with 
DN and Henoch Scholein purpura with DN. 
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 The pathological features of diabetic nephropathy observed were as 
follows ,mesangial expansion in 18,diffuse glomerulosclerosis in 10 
,nodular glomerularsclerosis in 6 and efferent arteriolar hyalinosis in 5. 
 
 The prevalence of non diabetic kidney disease in a proteinuric 
diabetic varies widely. Most Indian studies showed a prevalence from 30 % 
to 50 % .This wide variation in the incidence of non diabetic kidney disease, 
can be due to the differences in biopsy protocols for proteinuric diabetics in 
different units .The Dakshinamoorthy41 study showed a very high 
prevalence of NDN of 64 % .The biopsy protocol they followed was similar 
to ours but they had a significantly longer study period of 18 years and 
theirs was a retrospective study .Study by GT John42 et al in 1994 ,showed 
the prevalence of NDN to be 50 % in their study. 
 
 In Prakash3 et al study the prevalence of NDN was 43 % .Their study 
showed 50% of the NDN patients to have glomerular disease and the 
remaining 50 % tubulointerstitial disease .Membranous nephropathy was the 
most common glomerular disease in their study .The GT John42 study from 
south India showed proliferative glomerularnephritis to be the commonest 
NDN .Premlatha44 study showed showed membranous nephropathy to be 
the most common NDN ,in their study .These results show that the 
prevalence of different primary and secondary glomerular diseases(NDN) in 
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a diabetic, depends on the usual prevalence of these diseases based on their 
geographical and ethinic distribution , hence  is a coincidental finding. As 
per Bertani T46 et al the predisposition of DN to superimposed 
glomerularnephritis is due to the increased exposure to antigenic 
components causing immune response .Regarding the renal lesions in 
diabetic nephropathy ,the most common lesion was found to be diffuse 
glomerulosclerosis followed by nodular glomerulosclerosis in around 30 %. 
Prakash3 et al showed diffuse glomerosclerosis in 62 % and nodular 
sclerosis in 37 % respectively. 
 
 Risk factors in the biopsy proven diabetic nephropathy group were 
analysed ,they were 1)duration of diabetes, 2)patient age, 3)quantum of 
proteinuria, 4)presence of hypertension, 5)body mass index(BMI), 
6)estimated GFR and 7)serum cholesterol levels . 
 
1) Duration of diabetes  
 In both the DN and non DN group the most common duration of 
diabetes was between 2 to 5 years ,comprising 42 % and 63 % respectively. 
The duration of diabetes on analysis was found not to be significant risk 
factor for DN in our study. Teresa et al study showed a longer duration of 
diabetes in the group having DN compared to the non DN ,and this was 
significant in her study .However in other studies by Gwie45 et al and Soni43 
et al showed no significance of duration of diabtetes on presence of DN . 
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2) Patient age  
 The age group of 61 to 70 years was the most common age among 
patients of the DN group (42%) followed by the age group 51 to 60 years .In 
the non DN group the age group 41 to 50 years was the most common. 
Analysis of age as a risk factor for DN was found to be not statistically 
significant in our study .This finding was comparable to the Teresa40 
,Gwie45 and Soni43 studies also which showed no statistical significance of 
patient age on DN . 
 
3) Quantum of proteinuria  
 The quantum of proteinuria was similar (PCR 1.1 to 3.5 g/mg) in both 
the DN and non DN group comprising 63 % and 55 % respectively.The 
quantum of proteinuria was found not to be a significant factor to 
differentiate DN from non DN .This observation was made by both the 
Teresa40 et al and Dakshinamoorthy41 study which showed no significance 
of quantum of proteinuria on predicting DN . 
 
4) Hypertension  
 The presence of hypertension was analysed in both the DN and the 
non DN group. It was seen in 68 % and 55 % of patients in the DN and non 
DN group respectively which was not statistically significant .Teresa study 
was also of the similar opinion ,however the Dakshinamoorthy study 
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demonstrated a significant increase in the prevalence of hypertension in the 
DN group compared to the non DN group . 
 
5)Estimated GFR(eGFR)  
 45 % of the DN group had an eGFR of (45 to 59 ml/mt) while in the 
non DN group only 27 % were in this range of eGFR .We also found that 27 
% in the non DN group had an eGFR in the range of (16 – 30 ml/min) vs 
only 5 % in the DN group for the same eGFR range. Statistically however 
these differences were not significant .Teresa40 et al study showed higher 
creatinine values in the NDN group which were significant. 
Dakshinamoorthy41 et al also showed higher serum creatinine values in the 
NDN which were however not statistically significant. 
 
6) BMI and cholesterol levels as risk factors  
 The BMI in the DN and non DN group were similar with a mean BMI 
of 23 in both groups .In the Teresa et al study the BMI was 24 and 25 in the 
DN and non DN group respectively .The mean serum cholesterol levels 
were higher in the DN group than the non DN group (160 mg/dl vs 138 
mg/dl) .This difference was not statistically significant . 
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CONCORDANCE OF DIABETIC NEPHROPATHY AND 
RETINOPATHY 
 The presence of diabetic retinopathy was evaluated in each of the 
groups DN, non DN and the non DN superimposed on DN group .The 
results showed that 53 % of the patients with biopsy proven nephropathy 
had retinopathy but 47 % of the DN group did not have  retinopathy. 
 
 Similarly 36 % patients of the non DN group had diabetic retinopathy 
while 64%  did not . In the (NDN + DN) group 50 % had retinopathy .The 
sensitivity of retinopathy for nephropathy was 71.4 % with a specificity of 
63.6 % .Statistical analysis by Chi Squared testing showed that retinopathy 
was not  significant to differentiate DN from non DN (p value 0.6). 
 
 Parving4 et al in their study published in 1992 ,showed that 41 % of 
their patients with biopsy proven diabetic nephropathy lacked retinopathy 
.According to Parving the reason for this could be hemodynamic factors 
,causing impaired autoregulation and elevated glomerular hydraulic pressure 
this causes accelerated microangiopathy of the kidney compared to the 
retina .The Parving study also showed lack of retinopathy to be a poor 
predictor of non diabetic kidney disease .In the J Prakash3 study published 
in India 2007 showed their concordance of retinopathy and biopsy proven 
nephropathy to be 60 %.Their study also showed 40 % NDN patients to 
have retinopathy as well .They further concluded in their study that in the 
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absence of retinopathy there was  a 50 % chance of DN or non DN hence it 
is a poor predictor of non diabetic kidney disease .Teresa40 et al study 
showed absence of retinopathy to have a sensitivity of 82 % ,specificity of 
70 % and positive predictive value of 83 % in predicting non diabetic 
kidney disease .They further state that with absence of retinopathy and 
proteinuria > 2g/day taken together the positive predictive value increases to 
90 % . 
 
 Thus the concordance of diabetic nephropathy with retinopathy was 
53 % in our study, while in other studies it was around 60%. In the NDN 
group retinopathy was seen in 36 % which was comparable to other studies 
in which retinopathy was seen in upto 40%. 
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CONCLUSIONS 
 
1. The concordance between diabetic nephropathy and retinopathy was 
53 % in our study 
2. There was no difference between the diabetic nephropathy and non 
diabetic nephropathy group in terms of duration of diabetes ,age, 
quantum of proteinuria, estimated GFR and hypertension. 
3. The prevalence of non diabetic nephropathy was 34 % in our study. 
4. Retinopathy was seen in 36 % of the non diabetic nephropathy group 
as well. 
5. A renal biopsy is required for the accurate diagnosis of diabetic or 
non diabetic kidney disease in a proteinuric type 2 diabetic even in 
the presence of diabetic retinopathy . 
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PROFORMA 
 
Name  :                                              Age :                            Sex: 
 
Occupation: 
 
Address: 
 
Present complaints : 
 
Past history :     Diabetes :   Hypertension: 
 
Duration of diabetes : 
 
H/o Retinopathy: 
 
H/o Neuropathy : 
 
H/o Ischaemichea: 
 
Rt Disease :      H/o CVA : 
 
Hypertension – Duration  
 
Diabetes Treatment – OHA                                 Insulin – 
 
Family H/o – Diabetes                                           Hypertension – 
 
Personnel H/o – smoking                                        Alcohol- 
 
Marital status – 
 
Physical examination – 
 
1)Height                             2)weight                           3)BMI- 
 
4)Pulse rate                        5)Blood pressure -           6)peripheral pulses        
 
Fundus examination – 
 
Non diabetic nephropathy- 
 
Mild NPDR –                       Moderate NPDR –          Severe  
 
NPDR  - 
 
Proliferative diabetic nephropathy –                                     Macular edema – 
 
CVS-                                         RS-                                      CNS – 
 
Abdomen – 
 
Lab analysis – 
 
Urine analysis  -    protein            sediment 
 
Urine PCR   -  S.Creatinine -     Blood sugar –FBS      -PPBS 
 
Urine c/s –                                                              USG KUB – 
 
ECG –       ECHO – 
 
Renal biopsy - 
MASTER CHART 
 
   
  
  
   
   

CONSENT FORM 
TITLE OF PROJECT: 
“The concordance between Diabetic Nephropathy and Retinopathy 
in Type 2 Diabetes mellitus.” 
 
Name of Researcher: Dr. Andrew Deepak Rajiv 
Please tick to confirm 
 
•
I confirm that I have read and understand the information provided to me 
for the above study.  
 
 
 
•I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily.  
 
 
•
I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected.  
 
 
•I agree to take part in the above research study.  
 
 
 
 
__________________________ 
Name of Patient  
______________ 
Date 
__________________________ 
Signature 
 
_________________________ 
Name of Person taking consent  
(if different from researcher) 
_____________ 
Date 
__________________________ 
Signature 
 
 
Researcher 
______________ 
Date 
__________________________ 
Signature 
 
